Ascendis Pharma (ASND) PT Lowered to $326 at Wells Fargo
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $248.50 +0.92%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo analyst Chris M. Carey lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $326.00 (from $330.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Raised to $341 at TD Cowen
- Ascendis Pharma Reports Second Quarter 2026 Financial Results
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
